EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Varying Analgesic Effectiveness of Systemic and Central Intrathecal Administration of Cyclooxygenase‐2 Inhibitors in Different Phases of Osteoarthritic Pain in Rats

Chun-Sung Sung, Shi-Ying Huang, Hao-Jung Cheng, Sung-Chun Lin, Zong-Sheng Wu, Zhi-Kang Yao, Nan-Fu Chen, Yen-Hsuan Jean, Zhi-Hong Wen

European Journal of Pain · 2025

DOI: 10.1002/ejp.70068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pain, 2025. Verfasst von Chun-Sung Sung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pain Management, Department of Anesthesiology, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Cyclooxygenase 2 Inhibitors, Osteoarthritis, Pyridines, Sulfones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoarthritis (OA) contributes to heightened pain perception by disrupting the normal function of peripheral nerves and spinal nociceptive circuits. Although selective cyclooxygenase‐2 (COX‐2) inhibitors reduce OA‐associated pain, the distinct roles of spinal COX‐2 and glial cell activity in this context remain poorly defined.

Methods

The effects of two COX‐2 inhibitors, etoricoxib and celecoxib, were examined using an anterior cruciate ligament transection (ACLT) rat model of OA. Mechanical allodynia was assessed behaviorally using the von Frey filament test. COX‐2 protein expression and glial cell (astrocyte and microglia) activation in the lumbar spinal cord were analysed via immunohistochemistry.

Results

Spinal COX‐2 expression was significantly increased, mainly in neurons and astrocytes, at the 16th week after ACLT ( p = 0.026). Microglia and astrocytes were activated from the 2nd to 16th week and from the 6th to 16th week after ACLT, respectively. The intrathecal median effective dose (ED 50 ) of COX‐2 inhibitors, etoricoxib and celecoxib, required for reducing mechanical allodynia was lower at the 16th week than at the 2nd week after ACLT surgery ( p = 0.0448 and 0.046, respectively). In contrast, the oral ED 50 values of etoricoxib and celecoxib for relieving mechanical allodynia were slightly higher at the 16th week than at the 2nd week after ACLT surgery ( p = 0.097 and 0.227, respectively).

Conclusions

Our study shows that the efficacy of COX‐2 inhibitors in ALCT‐induced OA rats depends on the timing and route of administration. In the later phase, spinal glia cells exhibited increased activity and elevated COX‐2 expression. Significance This study characterises the complex mechanisms underlying OA pain, involving both peripheral and central components, and highlights the stage‐specific involvement of COX‐2, particularly in the spinal cord. It provides experimental evidence linking central COX‐2 activity and glial cell responses to OA pain, offering insights into the temporal dynamics of pain processing and guiding the development of therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclooxygenase 2 InhibitorsOsteoarthritisPyridinesSulfonesPyrazolesPainAnimalsCelecoxibEtoricoxibRatsMaleInjections, SpinalSpinal CordCyclooxygenase 2SulfonamidesRats, Sprague-DawleyHyperalgesiaAstrocytesDisease Models, AnimalMicrogliaNeuroglia

Stichwörter der Autor:innen

anterior cruciate ligament transectioncelecoxibcyclooxygenase‐2etoricoxibmechanical allodyniaosteoarthritis

Substanzen

Cyclooxygenase 2 InhibitorsCelecoxibEtoricoxibCyclooxygenase 2SulfonamidesPyridinesSulfonesPyrazoles

Autor:innen und Institutionen

  • Division of Pain Management, Department of Anesthesiology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan.
  • College of Ocean Food and Biological Engineering, Jimei University, Xiamen, China.
  • Department of Orthopedic Surgery, Pingtung Christian Hospital, Pingtung, Taiwan.
  • Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung, Taiwan.
  • Department of Orthopedic Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Zitieren

APA

Sung, C. S., Huang, S. Y., Cheng, H. J., Lin, S. C., Wu, Z. S., Yao, Z. K., Chen, N. F., Jean, Y. H., & Wen, Z. H. (2025). Varying Analgesic Effectiveness of Systemic and Central Intrathecal Administration of Cyclooxygenase‐2 Inhibitors in Different Phases of Osteoarthritic Pain in Rats. European Journal of Pain. https://doi.org/10.1002/ejp.70068

Vancouver

Sung CS, Huang SY, Cheng HJ, Lin SC, Wu ZS, Yao ZK, et al. Varying Analgesic Effectiveness of Systemic and Central Intrathecal Administration of Cyclooxygenase‐2 Inhibitors in Different Phases of Osteoarthritic Pain in Rats. European Journal of Pain. 2025. doi:10.1002/ejp.70068

BibTeX
@article{Sung2025,
  author = {Sung, Chun-Sung and Huang, Shi-Ying and Cheng, Hao-Jung and Lin, Sung-Chun and Wu, Zong-Sheng and Yao, Zhi-Kang and Chen, Nan-Fu and Jean, Yen-Hsuan and Wen, Zhi-Hong},
  title = {Varying Analgesic Effectiveness of Systemic and Central Intrathecal Administration of Cyclooxygenase‐2 Inhibitors in Different Phases of Osteoarthritic Pain in Rats},
  journal = {European Journal of Pain},
  year = {2025},
  doi = {10.1002/ejp.70068}
}
Kostenlos starten →